Furthermore, disrupting Cdk5 in rhabdomyosarcoma also led to IFN-γ-induced PD-L1 ineffectiveness, supporting a general role of Cdk5 in PD-L1 regulation in cancer cells. The gene discussed is CDK5; the disease is rhabdomyosarcoma.